News: McKesson Corp (MCK.N)

MCK.N on New York Stock Exchange

170.00USD
4:02pm EDT
Price Change (% chg)

$1.69 (+1.00%)
Prev Close
$168.31
Open
$170.12
Day's High
$170.93
Day's Low
$168.52
Volume
300,715
Avg. Vol
372,762
52-wk High
$188.00
52-wk Low
$102.68

Search Stocks
Select another date:

Mon, Apr 7 2014

McKesson extends offer period in Celesio takeover

FRANKFURT, April 7 - U.S. drugs wholesaler group McKesson on Monday said that shareholders in takeover target Celesio may tender their shares for an additional two-week acceptance period beginning on Tuesday.

Celesio sees adj EBIT returning to growth in 2014

FRANKFURT, March 18 - Celesio, the German drugs distributor being taken over by its U.S. peer McKesson, expects its underlying operating profit to return to growth this year as it expands its network of pharmacies.

BRIEF-McKesson takeover offer for Celesio runs Feb. 28 to April 2

FRANKFURT, Feb 28 - McKesson Corp Takeover offer for outstanding shares of Celesio AG runs February 28 to April 2 - offer document

RPT-Activist US investor Elliott ups exposure to Alliance Trust

LONDON, Feb 27 - U.S. activist investor Elliott Management Corp has increased its exposure to Scotland-based investment firm Alliance Trust Plc to more than 10 percent, a stock market filing showed.

Fitch Downgrades McKesson's L-T Rating to 'BBB+'; Outlook Negative

(The following statement was released by the rating agency) CHICAGO, February 06 (Fitch) Fitch Ratings has downgraded the long-term ratings of McKesson Corp. (NYSE: MCK), including the long-term Issuer Default Rating (IDR), to 'BBB+' from 'A-'. The Rating Outlook is Negative. A full list of rating actions follows at the end of this release. The rating actions follow the close of MCK's agreements with Franz Haniel & Cie GmbH (Haniel) and Elliott Fund Management (Elliott) to acquire the firms'

UPDATE 1-McKesson trims full-year outlook, cites taxes, charges

Jan 30 - U.S. pharmaceutical wholesaler McKesson Corp, which last week reached a deal to acquire Germany's Celesio AG, reported on Thursday a lower quarterly profit and trimmed its full-year outlook, citing higher taxes and one-time charges.

McKesson quarterly net profit falls, outlook lowered

- U.S. pharmaceutical wholesaler McKesson Corp , which last week reached a deal to acquire Germany's Celesio AG , reported on Thursday a 79 percent drop in quarterly net profit as one-time inventory and other charges offset revenue gains.

McKesson quarterly net profit falls, outlook lowered

Jan 30 - U.S. pharmaceutical wholesaler McKesson Corp, which last week reached a deal to acquire Germany's Celesio AG, reported on Thursday a 79 percent drop in quarterly net profit as one-time inventory and other charges offset revenue gains.

Elliott makes 13 percent profit on Celesio deal - analyst

FRANKFURT, Jan 30 - Hedge fund Elliott has made a return of about 13 percent on the bonds and shares it bought in Celesio, the German drug distributor being taken over by U.S rival McKesson, according to estimates by an analyst at Market Securities.

UPDATE 2-Elliott buries hatchet with McKesson over Celesio

* Elliott vows to abstain from further disruption - source

Select another date:
Search Stocks